Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-14 4:21 pm Sale | 13G | VERSARTIS INC ARAV | BAKER BROS. ADVISORS LP | 3,863,568 4.99% | -722,836 (-15.76%) | View |
2024-02-14 10:24 am Purchase | 13G | VERSARTIS INC ARAV | BIOTECHNOLOGY VALUE FUND L P | 8,164,510 9.99% | 2,055,452 (+33.65%) | View |
2024-02-09 5:14 pm Sale | 13G | VERSARTIS INC ARAV | Artal International S.C.A. | 7,609,522 9.4% | -4,572,515 (-37.53%) | View |
2023-02-14 4:00 pm Purchase | 13G | VERSARTIS INC ARAV | BAKER BROS. ADVISORS LP | 4,586,404 7.5% | 4,586,404 (New Position) | View |
2023-02-10 7:28 pm Purchase | 13G | VERSARTIS INC ARAV | Artal International S.C.A. | 12,182,037 9.9% | 10,870,746 (+829.01%) | View |
2022-12-28 4:00 pm Purchase | 13D | VERSARTIS INC ARAV | Zhang Eric | 2,029,634 3.4% | 1,169,868 (+136.07%) | View |
2022-12-27 4:05 pm Purchase | 13D | VERSARTIS INC ARAV | Giaccia Amato | 1,725,244 2.9% | 546,932 (+46.42%) | View |
2022-11-07 4:50 pm Purchase | 13G | VERSARTIS INC ARAV | BIOTECHNOLOGY VALUE FUND L P | 6,109,058 9.99% | 6,109,058 (New Position) | View |
2022-11-03 4:45 pm Purchase | 13D | VERSARTIS INC ARAV | Eshelman Ventures LLC | 26,451,103 43.6% | 26,451,103 (New Position) | View |
2022-04-05 4:15 pm Purchase | 13D | VERSARTIS INC ARAV | ESHELMAN FREDRIC N | 10,111,882 34% | 5,806,201 (+134.85%) | View |
2022-02-11 4:48 pm Unchanged | 13G | VERSARTIS INC ARAV | New Leaf Biopharma Opportunities II L.P. | 946,423 4.5% | 0 (Unchanged) | View |
2022-01-05 6:32 pm Purchase | 13D | VERSARTIS INC ARAV | ESHELMAN FREDRIC N | 4,305,681 19.99% | 472,828 (+12.34%) | View |
2021-04-15 07:00 am Sale | 13D | VERSARTIS INC ARAV | Tabibiazar Raymond | 1,606,511 7.9% | -29,074 (-1.78%) | View |
2021-03-23 07:05 am Purchase | 13D | VERSARTIS INC ARAV | Giaccia Amato | 1,178,312 5.9% | 15,704 (+1.35%) | View |
2021-02-18 7:55 pm Sale | 13D | VERSARTIS INC ARAV | Liu Qianye | 449,910 2.8% | -409,856 (-47.67%) | View |
2021-02-18 7:00 pm Purchase | 13D | VERSARTIS INC ARAV | ESHELMAN FREDRIC N | 3,832,853 19.8% | 2,901,755 (+311.65%) | View |
2021-02-12 8:45 pm Sale | 13G | VERSARTIS INC ARAV | Artal International S.C.A. | 1,311,291 8.2% | -38,709 (-2.87%) | View |
2020-04-15 7:56 pm Purchase | 13D | VERSARTIS INC ARAV | ESHELMAN FREDRIC N | 931,098 5.8% | 931,098 (New Position) | View |
2020-02-12 5:36 pm Sale | 13G | VERSARTIS INC ARAV | New Leaf Biopharma Opportunities II L.P. | 946,423 6.3% | -24,236 (-2.50%) | View |
2019-12-10 4:16 pm Purchase | 13G | VERSARTIS INC ARAV | Artal International S.C.A. | 1,350,000 9% | 1,350,000 (New Position) | View |